Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Suo Quan Wan (SQW) is a traditional Chinese medicine (TCM) herbal formulation composed of *Alpinia oxyphylla* Miq., *Dioscorea opposita* Thunb., and *Radix Lindera* in a 1:1:1 ratio. Traditionally used in TCM to warm kidney yang and treat conditions such as frequent urination and urinary incontinence, it is being investigated for its potential therapeutic effects in managing clozapine-induced hypersalivation (sialorrhea). The Psychiatry Department at Taichung Veterans General Hospital evaluated the formulation in a Phase 2 randomized, placebo-controlled clinical trial to determine if it can reduce excessive salivation in patients with schizophrenia, thereby improving medication compliance and overall quality of life.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Suo Quan Wan.